| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1B CACNA1E PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 SEC61A1 | 1.14e-08 | 129 | 167 | 11 | GO:0005262 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1B CACNA1E PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 SEC61A1 | 5.89e-08 | 151 | 167 | 11 | GO:0015085 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1B CACNA1E PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 ANO6 KCNAB1 KCNQ3 SEC61A1 | 1.20e-06 | 343 | 167 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.28e-06 | 4 | 167 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.43e-06 | 14 | 167 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.57e-06 | 33 | 167 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1B CACNA1E CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 ANO6 KCNAB1 KCNQ3 SEC61A1 | 7.59e-06 | 459 | 167 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B CACNA1E MRS2 PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 SLC12A3 KCNAB1 KCNQ3 SEC61A1 | 8.86e-06 | 465 | 167 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.13e-05 | 6 | 167 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.32e-05 | 18 | 167 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.53e-05 | 21 | 167 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1B CACNA1E CFTR CATSPER3 RYR1 RYR2 RYR3 ITPR2 CACNG3 ANO6 KCNAB1 KCNQ3 | 2.55e-05 | 334 | 167 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | channel activity | CACNA1B CACNA1E CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 ANO6 KCNAB1 KCNQ3 SEC61A1 | 3.65e-05 | 525 | 167 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1B CACNA1E CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 ANO6 KCNAB1 KCNQ3 SEC61A1 | 3.73e-05 | 526 | 167 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.00e-05 | 46 | 167 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 9.02e-05 | 11 | 167 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B CACNA1E MRS2 CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 SLC12A3 ATP11B ANO6 KCNAB1 KCNQ3 SEC61A1 | 1.20e-04 | 793 | 167 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.24e-04 | 31 | 167 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B CACNA1E MRS2 PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 SLC12A3 ANO6 KCNAB1 KCNQ3 SEC61A1 | 1.48e-04 | 664 | 167 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.51e-04 | 182 | 167 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.63e-04 | 184 | 167 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | kinase binding | CDKN2B MYOM1 TOM1L1 DGKQ IRS1 MAPKAPK5 LYST STX1B RYR2 TAOK2 KIF20A PTPN14 RHOBTB1 ZPR1 PKP2 KIF14 KCNQ3 JAKMIP1 GNAT1 RAPGEF2 | 1.78e-04 | 969 | 167 | 20 | GO:0019900 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B CACNA1E MRS2 CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 SLC12A3 ANO6 KCNAB1 KCNQ3 SEC61A1 | 2.15e-04 | 758 | 167 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.51e-04 | 37 | 167 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B CACNA1E MRS2 PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 SLC12A3 KCNAB1 KCNQ3 SEC61A1 | 2.59e-04 | 627 | 167 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.79e-04 | 38 | 167 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.79e-04 | 38 | 167 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.96e-04 | 152 | 167 | 7 | GO:0022843 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.01e-04 | 70 | 167 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B EIF4A3 CFTR MCM6 FANCM KIF20A DNAH12 ATP11B EIF4A1 KIF14 POLQ DDX41 | 3.48e-04 | 441 | 167 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.93e-04 | 123 | 167 | 6 | GO:0030165 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B DNHD1 EIF4A3 CFTR MCM6 ACSF2 FANCM KIF20A DNAH12 ATP11B EIF4A1 KIF14 POLQ DDX41 | 6.69e-04 | 614 | 167 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | protein kinase binding | CDKN2B TOM1L1 IRS1 MAPKAPK5 LYST STX1B RYR2 TAOK2 KIF20A PTPN14 RHOBTB1 ZPR1 PKP2 KIF14 KCNQ3 GNAT1 RAPGEF2 | 1.06e-03 | 873 | 167 | 17 | GO:0019901 |
| GeneOntologyMolecularFunction | protein domain specific binding | ABI3 REPS1 CFTR ESRRG TOM1L1 ZMYND8 IRS1 XPO1 STX1B CACNG3 USHBP1 KIF14 KCNAB1 GPSM2 DMD RAPGEF2 OLIG2 | 1.09e-03 | 875 | 167 | 17 | GO:0019904 |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 1.15e-03 | 25 | 167 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 UBR2 KMT2B ESRRG ZMYND8 ERVK-7 PDXK NR1I2 PIAS3 ZPR1 ERVK-8 KMT2A POLR1B ERVK-19 DMD TRIM44 RABGGTB | 1.32e-03 | 891 | 167 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.61e-03 | 28 | 167 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.88e-03 | 8 | 167 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | helicase activity | 2.16e-03 | 158 | 167 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B EIF4A3 CFTR MCM6 FANCM KIF20A DNAH12 GNA14 RHOBTB1 ATP11B EIF4A1 KIF14 GNAT1 POLQ DDX41 | 2.21e-03 | 775 | 167 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 2.41e-03 | 9 | 167 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 2.41e-03 | 9 | 167 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.99e-03 | 10 | 167 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | metallodipeptidase activity | 2.99e-03 | 10 | 167 | 2 | GO:0070573 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 2.99e-03 | 10 | 167 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.15e-03 | 118 | 167 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.28e-03 | 230 | 167 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.29e-03 | 172 | 167 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | channel regulator activity | 3.48e-03 | 174 | 167 | 6 | GO:0016247 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.62e-03 | 37 | 167 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.62e-03 | 37 | 167 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.79e-03 | 177 | 167 | 6 | GO:0141108 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 4.16e-03 | 78 | 167 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | calcium ion binding | CACNA1B CACNA1E CLXN REPS1 GNPTAB PKDREJ RYR1 RYR2 RYR3 ITPR2 FAT2 GCA TESC RAPGEF2 | 4.21e-03 | 749 | 167 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | metal-dependent deubiquitinase activity | 4.34e-03 | 12 | 167 | 2 | GO:0140492 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 4.34e-03 | 12 | 167 | 2 | GO:0140852 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 4.56e-03 | 80 | 167 | 4 | GO:0008186 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B EIF4A3 CFTR MCM6 FANCM KIF20A DNAH12 GNA14 RHOBTB1 ATP11B EIF4A1 KIF14 GNAT1 POLQ DDX41 | 4.64e-03 | 839 | 167 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1B CACNA1E MRS2 CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 SEC61A2 SLC12A3 ATP11B ANO6 KCNAB1 KCNQ3 SEC61A1 | 4.67e-03 | 1180 | 167 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B EIF4A3 CFTR MCM6 FANCM KIF20A DNAH12 GNA14 RHOBTB1 ATP11B EIF4A1 KIF14 GNAT1 POLQ DDX41 | 4.69e-03 | 840 | 167 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B EIF4A3 CFTR MCM6 FANCM KIF20A DNAH12 GNA14 RHOBTB1 ATP11B EIF4A1 KIF14 GNAT1 POLQ DDX41 | 4.69e-03 | 840 | 167 | 15 | GO:0016818 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B CACNA1E LPAR3 MRS2 CFTR PKD1L1 LMTK2 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 AKAP9 SLC12A3 ANO6 PKP2 KCNAB1 KCNQ3 TESC DMD SEC61A1 | 6.11e-06 | 1000 | 167 | 23 | GO:0030001 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 8.61e-06 | 166 | 167 | 9 | GO:0014074 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.51e-05 | 178 | 167 | 9 | GO:0006261 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1B CACNA1E PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 ANO6 DMD SEC61A1 | 1.93e-05 | 392 | 167 | 13 | GO:0070588 |
| GeneOntologyBiologicalProcess | response to caffeine | 2.23e-05 | 21 | 167 | 4 | GO:0031000 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer morphogenesis | 4.59e-05 | 25 | 167 | 4 | GO:0021692 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B CACNA1E MRS2 CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 AKAP9 SLC12A3 ANO6 KCNAB1 KCNQ3 TESC DMD SEC61A1 | 5.89e-05 | 922 | 167 | 20 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B CACNA1E LPAR3 MRS2 CFTR PKD1L1 LMTK2 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 AKAP9 SLC12A3 ANO6 PKP2 KCNAB1 KCNQ3 TESC DMD SEC61A1 | 6.10e-05 | 1157 | 167 | 23 | GO:0006812 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1B CACNA1E LPAR3 PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 ANO6 DMD SEC61A1 | 7.12e-05 | 509 | 167 | 14 | GO:0006816 |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 7.12e-05 | 217 | 167 | 9 | GO:0021953 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B CACNA1E MRS2 CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 AKAP9 SLC12A3 ANO6 KCNAB1 KCNQ3 TESC DMD SEC61A1 | 7.91e-05 | 942 | 167 | 20 | GO:0098655 |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 8.20e-05 | 11 | 167 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | EPHB2 CACNA1B CACNA1E MRS2 CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 AKAP9 SLC12A3 ATP11B ANO6 KCNAB1 KCNQ3 TESC DMD SEC61A1 | 9.96e-05 | 1115 | 167 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | EPHB2 CACNA1B CACNA1E LPAR3 MRS2 CFTR PKD1L1 LMTK2 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 AKAP9 SLC12A3 ATP11B ANO6 PKP2 KCNAB1 KCNQ3 TESC DMD SEC61A1 | 1.17e-04 | 1374 | 167 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | microtubule-based process | DRC7 KIF21B DNHD1 CACNA1E DCAF13 CLXN CATSPER3 XPO1 LYST KIF20A AP3S1 HOOK3 DNAH12 AKAP9 ZPR1 TTC21B KIF14 GPSM2 ZW10 CAMSAP1 STAG2 | 1.34e-04 | 1058 | 167 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 1.38e-04 | 97 | 167 | 6 | GO:0032414 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.40e-04 | 13 | 167 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 1.60e-04 | 142 | 167 | 7 | GO:0046683 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.78e-04 | 14 | 167 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B CACNA1E MRS2 CFTR PKD1L1 CATSPER3 PKDREJ RYR1 RYR2 RYR3 ITPR2 CACNG3 AKAP9 SLC12A3 ANO6 KCNAB1 KCNQ3 TESC DMD SEC61A1 | 2.20e-04 | 1017 | 167 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 2.22e-04 | 37 | 167 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 2.37e-04 | 107 | 167 | 6 | GO:0032411 | |
| GeneOntologyBiologicalProcess | DNA replication | 2.37e-04 | 312 | 167 | 10 | GO:0006260 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 2.70e-04 | 259 | 167 | 9 | GO:0051651 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 2.73e-04 | 39 | 167 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer development | 2.73e-04 | 39 | 167 | 4 | GO:0021680 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 LPAR3 ABI3 PLEKHG4 ZMYND8 ADGRB3 LMTK2 RRN3P2 BRINP1 ADNP MAPKAPK5 STX1B TAOK2 OLIG3 STX3 SEMA6D FARP1 ZPR1 KCNQ3 GNAT1 DMD HERC1 RAPGEF2 CAMSAP1 OLIG2 | 3.08e-04 | 1463 | 167 | 25 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 3.28e-04 | 266 | 167 | 9 | GO:0043270 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell differentiation | 3.89e-04 | 18 | 167 | 3 | GO:0021702 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 4.37e-04 | 44 | 167 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | membrane organization | EPHB2 CACNA1B HK2 ZMYND8 HUWE1 EYA2 AKAP8L STX1B KIF20A AP3S1 STX3 ATP11B ANO6 FARP1 GCA ARHGAP25 SEC61A1 BAG6 | 4.54e-04 | 914 | 167 | 18 | GO:0061024 |
| GeneOntologyCellularComponent | calcium channel complex | 1.21e-07 | 73 | 167 | 8 | GO:0034704 | |
| GeneOntologyCellularComponent | cation channel complex | CACNA1B CACNA1E PKD1L1 CATSPER3 RYR1 RYR2 RYR3 CACNG3 AKAP9 KCNAB1 KCNQ3 | 3.11e-06 | 235 | 167 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1B CACNA1E CFTR PKD1L1 CATSPER3 RYR1 RYR2 RYR3 CACNG3 AKAP9 ANO6 KCNAB1 KCNQ3 | 1.14e-05 | 378 | 167 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.22e-05 | 46 | 167 | 5 | GO:0005891 | |
| GeneOntologyCellularComponent | paraspeckles | 5.77e-05 | 10 | 167 | 3 | GO:0042382 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 KIF21B CACNA1B CACNA1E ABI3 EIF4A3 CFTR ZMYND8 LMTK2 BRINP1 ADNP TAOK2 CACNG3 STX3 AKAP9 PIAS3 FARP1 ZPR1 KCNAB1 KCNQ3 GNAT1 DMD RAPGEF2 | 1.22e-04 | 1228 | 167 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.24e-04 | 185 | 167 | 8 | GO:0009898 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1B CACNA1E CFTR PKD1L1 CATSPER3 RYR1 RYR2 RYR3 CACNG3 AKAP9 ATP11B ANO6 KCNAB1 KCNQ3 | 1.40e-04 | 550 | 167 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1B CACNA1E CFTR PKD1L1 CATSPER3 RYR1 RYR2 RYR3 CACNG3 AKAP9 ANO6 KCNAB1 KCNQ3 | 3.05e-04 | 523 | 167 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1B CACNA1E HLA-DQA2 CFTR PKD1L1 EVC CATSPER3 IRS1 STX1B RYR1 RYR2 RYR3 CACNG3 SEC61A2 AP3S1 STX3 HOOK3 GNA14 AKAP9 ANO6 KCNAB1 KCNQ3 GNAT1 DMD SEC61A1 | 3.59e-04 | 1498 | 167 | 25 | GO:0098796 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 4.54e-04 | 45 | 167 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | dendrite | EPHB2 KIF21B CACNA1B ABI3 EIF4A3 CFTR ZMYND8 BRINP1 ADNP TAOK2 CACNG3 STX3 AKAP9 PIAS3 FARP1 KCNAB1 KCNQ3 | 5.28e-04 | 858 | 167 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 5.38e-04 | 230 | 167 | 8 | GO:0098562 | |
| GeneOntologyCellularComponent | dendritic tree | EPHB2 KIF21B CACNA1B ABI3 EIF4A3 CFTR ZMYND8 BRINP1 ADNP TAOK2 CACNG3 STX3 AKAP9 PIAS3 FARP1 KCNAB1 KCNQ3 | 5.42e-04 | 860 | 167 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | Sec61 translocon complex | 6.24e-04 | 5 | 167 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 7.04e-04 | 88 | 167 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 8.25e-04 | 137 | 167 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | translocon complex | 9.32e-04 | 6 | 167 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 1.04e-03 | 56 | 167 | 4 | GO:0031234 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum membrane | 1.57e-03 | 29 | 167 | 3 | GO:0030867 | |
| GeneOntologyCellularComponent | junctional membrane complex | 2.20e-03 | 9 | 167 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.23e-03 | 114 | 167 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | nuclear body | CASP8AP2 EIF4A3 DGKQ XPO1 BCL6 PRPF8 AKAP8L EIF2D NR1I2 PIAS3 LUC7L2 ZPR1 GEMIN4 CDT1 PSPC1 NONO | 2.43e-03 | 903 | 167 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 2.55e-03 | 230 | 167 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | nuclear periphery | 2.55e-03 | 171 | 167 | 6 | GO:0034399 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.74e-03 | 10 | 167 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 2.74e-03 | 10 | 167 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 CACNA1B CACNA1E EIF4A3 CFTR LMTK2 BRINP1 ADNP AKAP9 ZPR1 KCNAB1 KCNQ3 GNAT1 DMD RAPGEF2 | 2.91e-03 | 835 | 167 | 15 | GO:0043025 |
| Domain | RIH_assoc-dom | 7.68e-08 | 6 | 160 | 4 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.68e-08 | 6 | 160 | 4 | PF08709 | |
| Domain | RIH_assoc | 7.68e-08 | 6 | 160 | 4 | PF08454 | |
| Domain | RIH_dom | 7.68e-08 | 6 | 160 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.68e-08 | 6 | 160 | 4 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.68e-08 | 6 | 160 | 4 | IPR015925 | |
| Domain | - | 7.68e-08 | 6 | 160 | 4 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.68e-08 | 6 | 160 | 4 | PF01365 | |
| Domain | Ryanodine_rcpt | 6.17e-07 | 3 | 160 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 6.17e-07 | 3 | 160 | 3 | IPR009460 | |
| Domain | RyR | 6.17e-07 | 3 | 160 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 6.17e-07 | 3 | 160 | 3 | PF06459 | |
| Domain | Ryan_recept | 6.17e-07 | 3 | 160 | 3 | IPR013333 | |
| Domain | MIR | 1.05e-06 | 10 | 160 | 4 | PF02815 | |
| Domain | MIR_motif | 1.05e-06 | 10 | 160 | 4 | IPR016093 | |
| Domain | MIR | 1.05e-06 | 10 | 160 | 4 | PS50919 | |
| Domain | MIR | 1.05e-06 | 10 | 160 | 4 | SM00472 | |
| Domain | Ion_trans_dom | 6.21e-06 | 114 | 160 | 8 | IPR005821 | |
| Domain | Ion_trans | 6.21e-06 | 114 | 160 | 8 | PF00520 | |
| Domain | EF_hand_dom | 3.23e-05 | 232 | 160 | 10 | IPR002048 | |
| Domain | SecY_su_dom | 7.29e-05 | 2 | 160 | 2 | IPR023201 | |
| Domain | SECY_1 | 7.29e-05 | 2 | 160 | 2 | PS00755 | |
| Domain | SECY_2 | 7.29e-05 | 2 | 160 | 2 | PS00756 | |
| Domain | - | 7.29e-05 | 2 | 160 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 7.29e-05 | 2 | 160 | 2 | IPR019561 | |
| Domain | SecY_CS | 7.29e-05 | 2 | 160 | 2 | IPR030659 | |
| Domain | MeTrfase_trithorax | 7.29e-05 | 2 | 160 | 2 | IPR016569 | |
| Domain | Plug_translocon | 7.29e-05 | 2 | 160 | 2 | PF10559 | |
| Domain | MCC-bdg_PDZ | 7.29e-05 | 2 | 160 | 2 | PF10506 | |
| Domain | SecY | 7.29e-05 | 2 | 160 | 2 | PF00344 | |
| Domain | USH1C-bd_PDZ_domain | 7.29e-05 | 2 | 160 | 2 | IPR019536 | |
| Domain | SecY/SEC61-alpha | 7.29e-05 | 2 | 160 | 2 | IPR002208 | |
| Domain | ARM-type_fold | XPO1 HUWE1 LYST RYR3 ITPR2 RIC8B NCAPG HEATR6 PKP2 PDS5A STAG2 | 1.68e-04 | 339 | 160 | 11 | IPR016024 |
| Domain | EF_HAND_2 | 1.73e-04 | 231 | 160 | 9 | PS50222 | |
| Domain | EF-hand-dom_pair | 1.88e-04 | 287 | 160 | 10 | IPR011992 | |
| Domain | NOPS | 2.18e-04 | 3 | 160 | 2 | IPR012975 | |
| Domain | NOPS | 2.18e-04 | 3 | 160 | 2 | PF08075 | |
| Domain | GPS | 2.75e-04 | 37 | 160 | 4 | IPR000203 | |
| Domain | EF-hand_1 | 3.40e-04 | 152 | 160 | 7 | PF00036 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.07e-04 | 73 | 160 | 5 | IPR011545 | |
| Domain | DEAD | 4.07e-04 | 73 | 160 | 5 | PF00270 | |
| Domain | FOXP-CC | 4.33e-04 | 4 | 160 | 2 | PF16159 | |
| Domain | FOXP-CC | 4.33e-04 | 4 | 160 | 2 | IPR032354 | |
| Domain | EYA_dom | 4.33e-04 | 4 | 160 | 2 | IPR006545 | |
| Domain | EYA_fam | 4.33e-04 | 4 | 160 | 2 | IPR028472 | |
| Domain | REJ | 4.33e-04 | 4 | 160 | 2 | PS51111 | |
| Domain | REJ_dom | 4.33e-04 | 4 | 160 | 2 | IPR014010 | |
| Domain | FYrich_C | 7.17e-04 | 5 | 160 | 2 | IPR003889 | |
| Domain | FYrich_N | 7.17e-04 | 5 | 160 | 2 | IPR003888 | |
| Domain | FYRC | 7.17e-04 | 5 | 160 | 2 | SM00542 | |
| Domain | FYRN | 7.17e-04 | 5 | 160 | 2 | SM00541 | |
| Domain | Prenyltrans | 7.17e-04 | 5 | 160 | 2 | PF00432 | |
| Domain | PFTB_repeat | 7.17e-04 | 5 | 160 | 2 | IPR001330 | |
| Domain | FYRN | 7.17e-04 | 5 | 160 | 2 | PF05964 | |
| Domain | FYRC | 7.17e-04 | 5 | 160 | 2 | PF05965 | |
| Domain | FYRC | 7.17e-04 | 5 | 160 | 2 | PS51543 | |
| Domain | FYRN | 7.17e-04 | 5 | 160 | 2 | PS51542 | |
| Domain | P-loop_NTPase | KIF21B DNHD1 EIF4A3 CFTR MCM6 IQCN FANCM KIF20A DNAH12 GNA14 RHOBTB1 EIF4A1 KIF14 GNAT1 CAMTA1 POLQ DDX41 | 9.88e-04 | 848 | 160 | 17 | IPR027417 |
| Domain | PKD/REJ-like | 1.07e-03 | 6 | 160 | 2 | IPR002859 | |
| Domain | REJ | 1.07e-03 | 6 | 160 | 2 | PF02010 | |
| Domain | Ca_chan_IQ | 1.49e-03 | 7 | 160 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.49e-03 | 7 | 160 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.49e-03 | 7 | 160 | 2 | IPR014873 | |
| Domain | GPHH | 1.49e-03 | 7 | 160 | 2 | PF16905 | |
| Domain | GPHH_dom | 1.49e-03 | 7 | 160 | 2 | IPR031649 | |
| Domain | - | 1.88e-03 | 261 | 160 | 8 | 1.10.238.10 | |
| Domain | Helicase_C | 2.28e-03 | 107 | 160 | 5 | PF00271 | |
| Domain | HELICc | 2.28e-03 | 107 | 160 | 5 | SM00490 | |
| Domain | ARM-like | 2.32e-03 | 270 | 160 | 8 | IPR011989 | |
| Domain | DEAD_ATP_HELICASE | 2.33e-03 | 31 | 160 | 3 | PS00039 | |
| Domain | Helicase_C | 2.38e-03 | 108 | 160 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 2.47e-03 | 109 | 160 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.47e-03 | 109 | 160 | 5 | PS51192 | |
| Domain | DEXDc | 2.47e-03 | 109 | 160 | 5 | SM00487 | |
| Domain | SynN | 2.52e-03 | 9 | 160 | 2 | SM00503 | |
| Domain | Helicase_ATP-bd | 2.58e-03 | 110 | 160 | 5 | IPR014001 | |
| Domain | RNA-helicase_DEAD-box_CS | 2.79e-03 | 33 | 160 | 3 | IPR000629 | |
| Domain | GPS | 3.04e-03 | 34 | 160 | 3 | SM00303 | |
| Domain | EF-hand_8 | 3.04e-03 | 34 | 160 | 3 | PF13833 | |
| Domain | HEAT_REPEAT | 3.07e-03 | 70 | 160 | 4 | PS50077 | |
| Domain | VDCCAlpha1 | 3.14e-03 | 10 | 160 | 2 | IPR002077 | |
| Domain | GPS | 3.58e-03 | 36 | 160 | 3 | PS50221 | |
| Domain | Syntaxin | 3.81e-03 | 11 | 160 | 2 | PF00804 | |
| Domain | ZF_CXXC | 3.81e-03 | 11 | 160 | 2 | PS51058 | |
| Domain | Znf_CXXC | 3.81e-03 | 11 | 160 | 2 | IPR002857 | |
| Domain | PKD_channel | 3.81e-03 | 11 | 160 | 2 | PF08016 | |
| Domain | zf-CXXC | 3.81e-03 | 11 | 160 | 2 | PF02008 | |
| Domain | PKD1_2_channel | 3.81e-03 | 11 | 160 | 2 | IPR013122 | |
| Domain | Q_MOTIF | 3.87e-03 | 37 | 160 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 3.87e-03 | 37 | 160 | 3 | IPR014014 | |
| Domain | JAMM/MPN+_dom | 4.55e-03 | 12 | 160 | 2 | IPR000555 | |
| Domain | WWE | 4.55e-03 | 12 | 160 | 2 | PF02825 | |
| Domain | Syntaxin_N | 4.55e-03 | 12 | 160 | 2 | IPR006011 | |
| Domain | WWE-dom | 4.55e-03 | 12 | 160 | 2 | IPR004170 | |
| Domain | WWE | 4.55e-03 | 12 | 160 | 2 | PS50918 | |
| Domain | JAB_MPN | 4.55e-03 | 12 | 160 | 2 | SM00232 | |
| Domain | JAB | 4.55e-03 | 12 | 160 | 2 | PF01398 | |
| Domain | - | 4.55e-03 | 12 | 160 | 2 | 1.50.10.20 | |
| Domain | Kinesin_motor_CS | 5.18e-03 | 41 | 160 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 5.92e-03 | 43 | 160 | 3 | IPR027640 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.52e-08 | 11 | 128 | 5 | M47958 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.26e-05 | 19 | 128 | 4 | M47760 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.96e-04 | 13 | 128 | 3 | M39589 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.96e-04 | 13 | 128 | 3 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.96e-04 | 13 | 128 | 3 | M27661 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.18e-04 | 178 | 128 | 8 | M2890 | |
| Pubmed | HK2 REPS1 AGPAT2 NARS1 XPO1 HUWE1 PRPF8 AKAP8L PDXK ITPR2 NCAPG AP3S1 STX3 HOOK3 LUC7L2 EIF4A1 GEMIN4 KIF14 KMT2A PDS5A EIF3H ZW10 DDX41 SEC61A1 NONO BAG6 STAG2 | 1.59e-09 | 1440 | 168 | 27 | 30833792 | |
| Pubmed | 7.82e-09 | 6 | 168 | 4 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 7.82e-09 | 6 | 168 | 4 | 25966694 | |
| Pubmed | 7.82e-09 | 6 | 168 | 4 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 7.82e-09 | 6 | 168 | 4 | 16844763 | |
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 11860456 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 DCAF13 HK2 EIF4A3 MCM6 XPO1 HUWE1 PRPF8 ADNP PDXK RIC8B NCAPG TM9SF2 LUC7L2 EIF4A1 GEMIN4 KIF14 PDS5A EIF3H DDX41 PSPC1 SEC61A1 NONO BAG6 STAG2 | 2.54e-08 | 1425 | 168 | 25 | 30948266 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.82e-08 | 38 | 168 | 6 | 30786075 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | UBR2 EYA4 NARS1 XPO1 EYA2 SEC61A2 EIF2D PTPN14 AP3S1 HOOK3 MRPL16 GEMIN4 PKP2 KIF14 POLR1B DMD ZW10 SEC61A1 BAG6 PTPN20 | 2.85e-08 | 931 | 168 | 20 | 27432908 |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.62e-08 | 8 | 168 | 4 | 19033399 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF13 HK2 PLEKHG4 EIF4A3 NARS1 MCM6 XPO1 HUWE1 PRPF8 ADNP AKAP8L KIF20A EIF2D NCAPG PTPN14 AP3S1 EIF4A1 GEMIN4 PKP2 PDS5A POLR1B DDX41 NONO BAG6 | 4.05e-08 | 1353 | 168 | 24 | 29467282 |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 18403125 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 7876312 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.11e-07 | 3 | 168 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.11e-07 | 3 | 168 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.11e-07 | 3 | 168 | 3 | 10473538 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.11e-07 | 3 | 168 | 3 | 9204703 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.11e-07 | 3 | 168 | 3 | 12213830 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 9242641 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 25239916 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 18643873 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 11159936 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.11e-07 | 3 | 168 | 3 | 4600883 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 7635066 | ||
| Pubmed | CASP8AP2 KMT2B ACACB LCORL ZMYND8 HUWE1 ADNP AKAP8L LUC7L2 BUB1 GEMIN4 KIF14 CAMSAP1 | 1.43e-07 | 418 | 168 | 13 | 34709266 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.56e-07 | 170 | 168 | 9 | 16159877 | |
| Pubmed | ABI3 HK2 EIF4A3 XPO1 HUWE1 PRPF8 ITPR2 NCAPG ATP11B ANO6 EIF4A1 BUB1 GEMIN4 KIF14 LSS EIF3H ZW10 DDX41 NONO BAG6 STAG2 | 2.48e-07 | 1168 | 168 | 21 | 19946888 | |
| Pubmed | KIF21B UBR2 MRS2 MCM6 XPO1 HUWE1 AKAP8L TULP3 AKAP9 GEMIN4 EIF3H SEC61A1 BAG6 | 3.94e-07 | 457 | 168 | 13 | 22190034 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 4.41e-07 | 4 | 168 | 3 | 23413940 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 9607712 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 19120137 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 23482488 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 18206662 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 9384575 | ||
| Pubmed | REPS1 PLEKHG4 RBL1 EIF4A3 MCM6 XPO1 HUWE1 AKAP8L MRPL16 LUC7L2 FARP1 PKP2 KMT2A PDS5A ARHGAP25 DMD PSPC1 SEC61A1 | 5.38e-07 | 916 | 168 | 18 | 32203420 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | HK2 ZMYND8 NARS1 XPO1 HUWE1 PRPF8 NCAPG EIF4A1 PDS5A NONO STAG2 | 7.25e-07 | 332 | 168 | 11 | 32786267 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.10e-06 | 5 | 168 | 3 | 12629516 | |
| Pubmed | 1.10e-06 | 5 | 168 | 3 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.10e-06 | 5 | 168 | 3 | 19011160 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DCAF13 ACACB EIF4A3 ZMYND8 NARS1 MCM6 HUWE1 PRPF8 ADNP AKAP8L NCAPG AP3S1 MRPL16 LUC7L2 EIF4A1 KMT2A POLR1B DDX41 PSPC1 SEC61A1 NONO | 1.72e-06 | 1318 | 168 | 21 | 30463901 |
| Pubmed | 2.19e-06 | 6 | 168 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 2.19e-06 | 6 | 168 | 3 | 26025922 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 2.19e-06 | 6 | 168 | 3 | 14592808 | |
| Pubmed | 2.19e-06 | 6 | 168 | 3 | 19009018 | ||
| Pubmed | EIF4A3 MCM6 XPO1 HUWE1 PRPF8 NCAPG GEMIN4 PDS5A EIF3H ZW10 DDX41 NONO BAG6 STAG2 | 2.99e-06 | 638 | 168 | 14 | 33239621 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | HK2 SCAMP4 MCM6 XPO1 HUWE1 TAOK2 NCAPG TM9SF2 EIF4A1 GEMIN4 PDS5A LSS ZW10 SEC61A1 BAG6 STAG2 RABGGTB | 3.54e-06 | 942 | 168 | 17 | 31073040 |
| Pubmed | UBR2 EYA4 LMTK2 XPO1 HUWE1 EYA2 AKAP8L TULP3 ITPR2 NCAPG PTPN14 AKAP9 FARP1 KIF14 DMD HERC1 SEC61A1 PTPN20 | 3.63e-06 | 1049 | 168 | 18 | 27880917 | |
| Pubmed | 3.65e-06 | 131 | 168 | 7 | 34551306 | ||
| Pubmed | 3.82e-06 | 7 | 168 | 3 | 20962236 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KIF21B EIF4A3 ADGRB3 MCC NARS1 MCM6 PRPF8 NCAPG AP3S1 MRPL16 LUC7L2 EIF4A1 EIF3H PSPC1 NONO BAG6 | 3.93e-06 | 847 | 168 | 16 | 35235311 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | UBR2 EYA4 HK2 FOXP2 PLEKHG4 RBL1 ZMYND8 MCM6 HUWE1 PRPF8 ADNP FOXP4 NCAPG PDS5A CAMSAP1 STAG2 | 4.55e-06 | 857 | 168 | 16 | 25609649 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EIF4A3 HUWE1 PRPF8 EIF2D NCAPG GNA14 LUC7L2 EIF4A1 BUB1 GEMIN4 DDX41 NONO STAG2 | 5.64e-06 | 582 | 168 | 13 | 20467437 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B ACACB ZMYND8 XPO1 PRPF8 AKAP8L RYR3 DNAH12 LUC7L2 KMT2A HERC1 BAG6 | 6.00e-06 | 497 | 168 | 12 | 36774506 |
| Pubmed | 6.09e-06 | 8 | 168 | 3 | 11784029 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | DCAF13 ZMYND8 ADNP ITPR2 TAOK2 GEMIN4 KMT2A PDS5A DDX41 PSPC1 | 6.88e-06 | 341 | 168 | 10 | 32971831 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 8.39e-06 | 208 | 168 | 8 | 33230847 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | LCORL EIF4A3 ZMYND8 MCM6 PRPF8 ADNP AKAP8L LUC7L2 EIF4A1 GEMIN4 KMT2A DDX41 NONO | 8.53e-06 | 605 | 168 | 13 | 28977666 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | KIF21B CDKN2B DCAF13 KMT2B LCORL RBL1 BEX1 TOM1L1 ZMYND8 MCC ADNP MAPKAPK5 PIAS3 LUC7L2 EIF4A1 PDS5A ALAS1 BAG6 | 9.31e-06 | 1124 | 168 | 18 | 21900206 |
| Pubmed | UBR2 REPS1 EIF4A3 NARS1 MCM6 IRS1 XPO1 HUWE1 PRPF8 AKAP8L SEC61A2 EIF2D PTPN14 AKAP9 LUC7L2 EIF4A1 PKP2 SEC61A1 NONO | 1.04e-05 | 1247 | 168 | 19 | 27684187 | |
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 18434328 | ||
| Pubmed | Kif14 mutation causes severe brain malformation and hypomyelination. | 1.30e-05 | 10 | 168 | 3 | 23308235 | |
| Pubmed | ACACB EIF4A3 NARS1 MCM6 XPO1 HUWE1 LUC7L2 EIF4A1 SEC61A1 NONO | 1.64e-05 | 377 | 168 | 10 | 25147182 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HK2 EIF4A3 NARS1 MCM6 XPO1 HUWE1 PRPF8 NCAPG AP3S1 LUC7L2 EIF4A1 GEMIN4 PDS5A EIF3H DDX41 PSPC1 NONO BAG6 STAG2 RABGGTB | 1.78e-05 | 1415 | 168 | 20 | 28515276 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.79e-05 | 231 | 168 | 8 | 36597993 | |
| Pubmed | DCAF13 NARS1 MCM6 XPO1 HUWE1 PRPF8 ADNP EIF4A1 GEMIN4 KIF14 KMT2A PDS5A STAG2 | 1.90e-05 | 653 | 168 | 13 | 22586326 | |
| Pubmed | KIF21B CACNA1E FOXP2 ADGRB3 MCC HUWE1 ADNP TAOK2 HOOK3 AKAP9 FARP1 EIF4A1 KCNAB1 JAKMIP1 RAPGEF2 CAMSAP1 | 1.92e-05 | 963 | 168 | 16 | 28671696 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 1.93e-05 | 33 | 168 | 4 | 22357600 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FOXP2 ZMYND8 MCM6 CUEDC2 PIAS3 LUC7L2 PI4KB GPSM2 ALAS1 JAKMIP1 PSPC1 NONO | 1.96e-05 | 560 | 168 | 12 | 21653829 |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9792713 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26555638 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11790299 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15610184 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24486332 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20202939 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31201299 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9489997 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17259277 | ||
| Pubmed | Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia. | 2.32e-05 | 2 | 168 | 2 | 31395741 | |
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 2.32e-05 | 2 | 168 | 2 | 12640042 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 2.32e-05 | 2 | 168 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 2.32e-05 | 2 | 168 | 2 | 26009179 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32899693 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 14592949 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 8898078 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36781503 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 14550562 | ||
| Pubmed | Mitochondrial calcium overload is a key determinant in heart failure. | 2.32e-05 | 2 | 168 | 2 | 26217001 | |
| Pubmed | PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. | 2.32e-05 | 2 | 168 | 2 | 19564417 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24231659 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25100870 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9799464 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21099365 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 2.32e-05 | 2 | 168 | 2 | 15033925 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19298530 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 2.32e-05 | 2 | 168 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 2.32e-05 | 2 | 168 | 2 | 11500519 | |
| Interaction | UBR5 interactions | MRS2 EIF4A3 CFTR ESRRG XPO1 HUWE1 PRPF8 TULP3 KIF20A NR1I2 LUC7L2 EIF4A1 BUB1 KIF14 DDX41 NONO BAG6 | 2.06e-06 | 533 | 166 | 17 | int:UBR5 |
| Interaction | PWP2 interactions | 1.31e-05 | 172 | 166 | 9 | int:PWP2 | |
| Interaction | HDAC1 interactions | CASP8AP2 KMT2B ACACB SPI1 RBL1 ZMYND8 SALL4 BRINP1 XPO1 BCL6 ADNP AKAP8L KIF20A NCAPG AKAP9 PIAS3 BUB1 GEMIN4 KIF14 KMT2A CAMSAP1 NONO STAG2 MXD1 | 1.36e-05 | 1108 | 166 | 24 | int:HDAC1 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.02e-07 | 3 | 107 | 3 | 287 | |
| GeneFamily | EF-hand domain containing | 6.99e-07 | 219 | 107 | 10 | 863 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 2.07e-04 | 4 | 107 | 2 | 1044 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.75e-04 | 26 | 107 | 3 | 253 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.26e-04 | 181 | 107 | 6 | 694 | |
| GeneFamily | DEAD-box helicases | 1.96e-03 | 42 | 107 | 3 | 499 | |
| GeneFamily | Zinc fingers CXXC-type | 2.20e-03 | 12 | 107 | 2 | 136 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.54e-03 | 46 | 107 | 3 | 622 | |
| GeneFamily | Syntaxins | 3.94e-03 | 16 | 107 | 2 | 818 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 4.99e-03 | 18 | 107 | 2 | 812 | |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 1.47e-07 | 175 | 162 | 10 | M336 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | EPHB2 CASP8AP2 RBL1 MCM6 XPO1 FANCM ADNP MAPKAPK5 KIF20A SEC61A2 NCAPG PTPN14 CUEDC2 ANO6 LUC7L2 BUB1 KIF14 GCA GPSM2 POLR1B DMD CAMTA1 POLQ NONO RABGGTB | 1.86e-06 | 1407 | 162 | 25 | M14427 |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 4.53e-06 | 200 | 162 | 9 | M6254 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | HK2 RBL1 EIF4A3 PHTF2 MCM6 MAPKAPK5 KIF20A NCAPG BUB1 PKP2 KIF14 GPSM2 CDT1 | 5.86e-06 | 458 | 162 | 13 | M8520 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | MRS2 EIF4A3 MCM6 HUWE1 MAPKAPK5 KIF20A NCAPG EIF4A1 BUB1 KIF14 CDT1 EIF3H DDX41 NONO RABGGTB | 6.52e-06 | 612 | 162 | 15 | M4772 |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 | 1.91e-05 | 53 | 162 | 5 | M10169 | |
| Coexpression | GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP | 3.13e-05 | 196 | 162 | 8 | M8147 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | RBL1 TAOK2 NCAPG AKAP9 SLC12A3 CPQ PI4KB POLR1B NONO TRIM44 STAG2 | 3.23e-05 | 389 | 162 | 11 | M6520 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | CASP8AP2 LCORL RBL1 AGPAT2 NARS1 MCM6 UBALD2 XPO1 MAPKAPK5 PDXK KIF20A NCAPG BUB1 KIF14 GPSM2 ANKRD36 CDT1 CAMTA1 ZW10 POLQ DDX41 PSPC1 | 3.60e-05 | 1363 | 162 | 22 | M45782 |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_DN | 3.62e-05 | 200 | 162 | 8 | M5963 | |
| Coexpression | GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN | 3.62e-05 | 200 | 162 | 8 | M9528 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP | 3.62e-05 | 200 | 162 | 8 | M3776 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 3.62e-05 | 200 | 162 | 8 | M9203 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | EPHB2 CASP8AP2 ESRRG MCM6 XPO1 KIF20A TM9SF2 EIF4A1 BUB1 GEMIN4 POLR1B CDT1 DMD | 4.39e-05 | 555 | 162 | 13 | M2343 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | KIF21B UBR2 EYA4 HK2 SPI1 EIF4A3 MCC PHTF2 MCM6 XPO1 BCL6 ADNP TULP3 AP3S1 ATP11B PDS5A LSS ARHGAP25 EIF3H GNAT1 NONO STAG2 | 5.04e-05 | 1394 | 162 | 22 | M9585 |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 6.45e-05 | 68 | 162 | 5 | M41108 | |
| Coexpression | BIDUS_METASTASIS_UP | 7.31e-05 | 221 | 162 | 8 | M15866 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | HK2 EIF4A3 MCM6 XPO1 ADNP MAPKAPK5 NR1I2 AP3S1 ATP11B BUB1 KIF14 PDS5A CDT1 EIF3H NONO | 8.03e-05 | 761 | 162 | 15 | M11961 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 8.47e-05 | 290 | 162 | 9 | M45736 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 8.61e-05 | 116 | 162 | 6 | M2379 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 LCORL RBL1 XPO1 TULP3 NCAPG PTPN14 AKAP9 BUB1 GPSM2 PSPC1 | 8.62e-05 | 434 | 162 | 11 | M15150 |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 9.02e-05 | 117 | 162 | 6 | MM931 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.06e-04 | 233 | 162 | 8 | M13273 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 1.10e-04 | 300 | 162 | 9 | M39059 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.71e-04 | 250 | 162 | 8 | M11318 | |
| Coexpression | KIM_WT1_TARGETS_DN | ZMYND8 IRS1 KIF20A NCAPG RHOBTB1 PI4KB BUB1 KIF14 GPSM2 RAPGEF2 RABGGTB | 1.76e-04 | 471 | 162 | 11 | M17859 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 2.11e-04 | 402 | 162 | 10 | MM454 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 2.12e-04 | 194 | 162 | 7 | M7467 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_MAC_DN | 2.33e-04 | 197 | 162 | 7 | M5161 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 2.47e-04 | 199 | 162 | 7 | M9410 | |
| Coexpression | GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP | 2.47e-04 | 199 | 162 | 7 | M8000 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN | 2.55e-04 | 200 | 162 | 7 | M3365 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 2.55e-04 | 200 | 162 | 7 | M4538 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD4_TCELL_UP | 2.55e-04 | 200 | 162 | 7 | M4769 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN | 2.55e-04 | 200 | 162 | 7 | M9827 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 2.55e-04 | 200 | 162 | 7 | M5901 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN | 2.55e-04 | 200 | 162 | 7 | M7863 | |
| Coexpression | GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN | 2.55e-04 | 200 | 162 | 7 | M3074 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | LCORL PHTF2 RYR1 RYR2 ITPR2 SEC61A2 STX3 SEMA6D ATP11B JAKMIP1 HERC1 | 8.31e-07 | 219 | 159 | 11 | gudmap_developingGonad_e16.5_ovary_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | PLEKHG4 LCORL PHTF2 RYR1 RYR2 ITPR2 SEC61A2 NCAPG STX3 SEMA6D ATP11B LUC7L2 JAKMIP1 HERC1 CAMTA1 SEC61A1 NONO PTPN20 | 2.97e-05 | 795 | 159 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | EPHB2 CACNA1B LPAR3 EYA4 CLXN FOXP2 ESRRG SALL4 BRINP1 HUWE1 ADGRA2 RYR3 FOXP4 HEATR6 HOOK3 CAMTA1 CAMSAP1 TRIM44 | 3.55e-05 | 806 | 159 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CASP8AP2 DCAF13 BEX1 PHTF2 SALL4 HUWE1 LYST STX1B OLIG3 NCAPG ATP11B BUB1 KIF14 GCA GPSM2 DDHD2 HERC1 PTPN20 | 4.44e-05 | 820 | 159 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.94e-05 | 90 | 159 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1E FOXP2 RYR3 PPP1R1A CACNG3 ZFYVE28 KCNAB1 TESC JAKMIP1 | 3.64e-08 | 189 | 164 | 9 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1E FOXP2 RYR3 PPP1R1A CACNG3 ZFYVE28 KCNAB1 TESC JAKMIP1 | 3.64e-08 | 189 | 164 | 9 | 851f8144aed5c7f80302911cd6b03f14bde7b56d |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1E FOXP2 RYR3 PPP1R1A CACNG3 ZFYVE28 KCNAB1 TESC JAKMIP1 | 3.81e-08 | 190 | 164 | 9 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.45e-07 | 179 | 164 | 8 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-07 | 184 | 164 | 8 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-07 | 186 | 164 | 8 | 993c58ef4445bf81bbc9b489635883848b5b4c8e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 5.65e-07 | 191 | 164 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.05e-07 | 132 | 164 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.11e-07 | 193 | 164 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 6.36e-07 | 194 | 164 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-07 | 195 | 164 | 8 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.87e-07 | 196 | 164 | 8 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.87e-07 | 196 | 164 | 8 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.87e-07 | 196 | 164 | 8 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.87e-07 | 196 | 164 | 8 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.87e-07 | 196 | 164 | 8 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.87e-07 | 196 | 164 | 8 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class （2021.01.30） | 7.14e-07 | 197 | 164 | 8 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 7.41e-07 | 198 | 164 | 8 | 5c92687b853ebb00960adbef6552f9d460bc6886 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 7.70e-07 | 199 | 164 | 8 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Mild/Remission-Developping_Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.70e-07 | 199 | 164 | 8 | 58c772ec763109a4009f52424fbb214fc23d0c09 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.70e-07 | 199 | 164 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 7.70e-07 | 199 | 164 | 8 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 7.70e-07 | 199 | 164 | 8 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 8.00e-07 | 200 | 164 | 8 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.00e-07 | 200 | 164 | 8 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.00e-07 | 200 | 164 | 8 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.00e-07 | 200 | 164 | 8 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_Macrophages|Biopsy_IPF / Sample group, Lineage and Cell type | 8.00e-07 | 200 | 164 | 8 | 8abb2c25422717e994468ac02d8260344341467f | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.00e-07 | 200 | 164 | 8 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.00e-07 | 200 | 164 | 8 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | (24)_B_cell_cycling|World / shred on Cell_type and subtype | 8.62e-07 | 202 | 164 | 8 | a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.29e-06 | 161 | 164 | 7 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.80e-06 | 166 | 164 | 7 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-06 | 166 | 164 | 7 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-06 | 169 | 164 | 7 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.28e-06 | 170 | 164 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 171 | 164 | 7 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 171 | 164 | 7 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.55e-06 | 172 | 164 | 7 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-06 | 173 | 164 | 7 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-06 | 174 | 164 | 7 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-06 | 174 | 164 | 7 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-06 | 174 | 164 | 7 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 3.83e-06 | 174 | 164 | 7 | e4c8da80eca07e4396f57dad212f76c2eca4c1bd | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.98e-06 | 175 | 164 | 7 | 553e68e8b439a2293efb969e1e2aa017ceb80daf | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.98e-06 | 175 | 164 | 7 | 16d4e97271df1db9a0d167fc82a90d84d20dd1f2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.98e-06 | 175 | 164 | 7 | 289d2aa7164bc02b1876b99f2fb67baa8e030c4e | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.98e-06 | 175 | 164 | 7 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.98e-06 | 175 | 164 | 7 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-06 | 177 | 164 | 7 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-06 | 177 | 164 | 7 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 178 | 164 | 7 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 4.45e-06 | 178 | 164 | 7 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.96e-06 | 181 | 164 | 7 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 5.15e-06 | 182 | 164 | 7 | 6745d464c3ff289726aa8164e9a43f407f8e4380 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 5.33e-06 | 183 | 164 | 7 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.33e-06 | 183 | 164 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class （2021.01.30） | 5.33e-06 | 183 | 164 | 7 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 5.33e-06 | 183 | 164 | 7 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.53e-06 | 184 | 164 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.73e-06 | 185 | 164 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.73e-06 | 185 | 164 | 7 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.73e-06 | 185 | 164 | 7 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.73e-06 | 185 | 164 | 7 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-06 | 186 | 164 | 7 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.93e-06 | 186 | 164 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.15e-06 | 187 | 164 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.36e-06 | 188 | 164 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 6.36e-06 | 188 | 164 | 7 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | normal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-06 | 189 | 164 | 7 | 1d382f8eb998c6a30e09fddc9a427afc8f5f7323 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.59e-06 | 189 | 164 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-06 | 189 | 164 | 7 | b83fd81ecc5ef363be7435ee12cb7079e2434af7 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-06 | 189 | 164 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-06 | 189 | 164 | 7 | 3db4177d68cab4cd16842d2ebcaca28f69300e44 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.82e-06 | 190 | 164 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 6.82e-06 | 190 | 164 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.06e-06 | 191 | 164 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 7.06e-06 | 191 | 164 | 7 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.06e-06 | 191 | 164 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Cycling_Myeloid-Mac|GI_small-bowel / Manually curated celltypes from each tissue | 7.06e-06 | 191 | 164 | 7 | c3944332c5226b0113f8aa9ac07837b755606c6c | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 191 | 164 | 7 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.30e-06 | 192 | 164 | 7 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 7.30e-06 | 192 | 164 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.30e-06 | 192 | 164 | 7 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 192 | 164 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 192 | 164 | 7 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.55e-06 | 193 | 164 | 7 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 7.55e-06 | 193 | 164 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-06 | 194 | 164 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.81e-06 | 194 | 164 | 7 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-06 | 194 | 164 | 7 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 7.81e-06 | 194 | 164 | 7 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.81e-06 | 194 | 164 | 7 | e5b81a8e52259a54a911c1c2ac932c98c988318d | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-06 | 194 | 164 | 7 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.81e-06 | 194 | 164 | 7 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-06 | 194 | 164 | 7 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.81e-06 | 194 | 164 | 7 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| Drug | cis-diammineplatinum(II | 3.67e-07 | 3 | 164 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.67e-07 | 3 | 164 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 3.67e-07 | 3 | 164 | 3 | CID000127713 | |
| Drug | aminodantrolene | 3.67e-07 | 3 | 164 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 3.67e-07 | 3 | 164 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.67e-07 | 3 | 164 | 3 | CID005748312 | |
| Drug | PCB74 | 1.46e-06 | 4 | 164 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 1.46e-06 | 4 | 164 | 3 | CID006444275 | |
| Drug | SC 38249 | 1.46e-06 | 4 | 164 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 1.46e-06 | 4 | 164 | 3 | CID000035682 | |
| Drug | Cinildipine | 3.07e-06 | 56 | 164 | 6 | CID000002752 | |
| Drug | CNS 1145 | 3.68e-06 | 33 | 164 | 5 | CID000190902 | |
| Drug | IHC-64 | 3.68e-06 | 33 | 164 | 5 | CID000162753 | |
| Drug | nilvadipine | 4.63e-06 | 60 | 164 | 6 | CID000004494 | |
| Drug | IAA-94 | 5.10e-06 | 61 | 164 | 6 | CID000003667 | |
| Drug | DeltaR | 5.74e-06 | 17 | 164 | 4 | CID000028718 | |
| Drug | lercanidipine | 6.17e-06 | 63 | 164 | 6 | CID000065866 | |
| Drug | chloro-m-cresol | 7.22e-06 | 6 | 164 | 3 | CID000012008 | |
| Drug | MBED | 7.22e-06 | 6 | 164 | 3 | CID000129958 | |
| Drug | AC1O528X | 7.22e-06 | 6 | 164 | 3 | CID006475857 | |
| Drug | NSC114784 | 7.22e-06 | 6 | 164 | 3 | CID000419425 | |
| Drug | isradipine | 8.08e-06 | 100 | 164 | 7 | CID000003784 | |
| Drug | gallopamil | 8.84e-06 | 67 | 164 | 6 | CID000001234 | |
| Drug | AC1L2AC7 | 1.05e-05 | 69 | 164 | 6 | CID000068733 | |
| Drug | loperamide | 1.11e-05 | 105 | 164 | 7 | CID000003954 | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.15e-05 | 193 | 164 | 9 | 7388_DN | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.26e-05 | 7 | 164 | 3 | CID009547999 | |
| Drug | Azumoleno | 1.26e-05 | 7 | 164 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 1.26e-05 | 7 | 164 | 3 | CID003081001 | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; HL60; HG-U133A | BEX1 TOM1L1 MAPKAPK5 PDXK HEATR6 ATP11B LUC7L2 PI4KB RABGGTB | 1.41e-05 | 198 | 164 | 9 | 1619_DN |
| Drug | CAS 298-57-7 | 1.46e-05 | 73 | 164 | 6 | CID000002761 | |
| Drug | ethosuximide | 1.58e-05 | 74 | 164 | 6 | CID000003291 | |
| Drug | nisoldipine | 2.13e-05 | 78 | 164 | 6 | CID000004499 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.57e-05 | 164 | 164 | 8 | 3852_UP | |
| Drug | felodipine | 3.19e-05 | 169 | 164 | 8 | CID000003333 | |
| Drug | palbociclib | 3.47e-05 | 171 | 164 | 8 | ctd:C500026 | |
| Drug | bepridil | 3.64e-05 | 126 | 164 | 7 | CID000002351 | |
| Drug | PCB 95 | 4.24e-05 | 10 | 164 | 3 | CID000038012 | |
| Drug | 2,4-dinitroaniline | 4.24e-05 | 10 | 164 | 3 | CID000007321 | |
| Drug | Virginiamycin S1 | 4.64e-05 | 28 | 164 | 4 | CID000122731 | |
| Drug | aristolactam AII | 5.16e-05 | 2 | 164 | 2 | CID000148657 | |
| Drug | alkosin | 5.16e-05 | 2 | 164 | 2 | CID005488638 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 5.16e-05 | 2 | 164 | 2 | ctd:C005147 | |
| Drug | N-Formyl-Met-Val | 5.16e-05 | 2 | 164 | 2 | CID000100136 | |
| Drug | norcepharadione B | 5.16e-05 | 2 | 164 | 2 | CID000189168 | |
| Drug | piperolactam A | 5.16e-05 | 2 | 164 | 2 | CID003081016 | |
| Drug | Thimerosal | KIF21B DCAF13 HK2 REPS1 ACACB FOXP2 PLEKHG4 LCORL PHTF2 SALL4 AKAP8L RYR3 AKAP9 ATP11B GEMIN4 KMT2A LSS ALAS1 CDT1 RAPGEF2 STAG2 MXD1 | 5.20e-05 | 1199 | 164 | 22 | ctd:D013849 |
| Drug | PCB 66 | 5.80e-05 | 11 | 164 | 3 | CID000036185 | |
| Drug | R 478 | 5.80e-05 | 11 | 164 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 5.80e-05 | 11 | 164 | 3 | CID003081323 | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 6.06e-05 | 185 | 164 | 8 | 3241_DN | |
| Drug | 2,4-xylidinothiazoline | 6.14e-05 | 30 | 164 | 4 | CID000099296 | |
| Drug | LOPAC | 6.14e-05 | 30 | 164 | 4 | CID000062696 | |
| Drug | manidipine | 6.52e-05 | 95 | 164 | 6 | CID000004008 | |
| Drug | 9-methyluric acid | 7.02e-05 | 31 | 164 | 4 | CID000108714 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 7.31e-05 | 190 | 164 | 8 | 2619_DN | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 7.58e-05 | 191 | 164 | 8 | 2261_DN | |
| Drug | Ryanodine | 7.70e-05 | 12 | 164 | 3 | ctd:D012433 | |
| Drug | nitrendipine | 7.76e-05 | 98 | 164 | 6 | CID000004507 | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 7.86e-05 | 192 | 164 | 8 | 2865_DN | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A | 8.15e-05 | 193 | 164 | 8 | 1805_DN | |
| Drug | dihydropyridine | 8.15e-05 | 193 | 164 | 8 | CID000104822 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 4467_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 3862_UP | |
| Drug | Dantrolene-13C3 | 8.89e-05 | 145 | 164 | 7 | CID000002951 | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; PC3; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 4615_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; HL60; HG-U133A | 9.74e-05 | 198 | 164 | 8 | 1735_UP | |
| Drug | procaine | 1.24e-04 | 153 | 164 | 7 | CID000004914 | |
| Drug | bimoclomol | 1.26e-04 | 14 | 164 | 3 | CID009576891 | |
| Drug | lindane | 1.29e-04 | 154 | 164 | 7 | CID000000727 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.54e-04 | 3 | 164 | 2 | CID000080262 | |
| Drug | flubendiamide | 1.54e-04 | 3 | 164 | 2 | CID011193251 | |
| Drug | butamben | 1.57e-04 | 15 | 164 | 3 | CID000002482 | |
| Drug | FPL 64176 | 1.57e-04 | 15 | 164 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 1.57e-04 | 15 | 164 | 3 | CID000125015 | |
| Drug | AC1L98DX | 1.58e-04 | 38 | 164 | 4 | CID000439957 | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 160 | 164 | 7 | 5275_UP | |
| Drug | NAADP | 1.75e-04 | 39 | 164 | 4 | CID000123952 | |
| Drug | CID9959010 | 1.75e-04 | 39 | 164 | 4 | CID009959010 | |
| Drug | Methacholine Chloride | 1.92e-04 | 16 | 164 | 3 | ctd:D016210 | |
| Drug | epps | 1.94e-04 | 40 | 164 | 4 | CID000085255 | |
| Drug | lamotrigine | 1.97e-04 | 116 | 164 | 6 | CID000003878 | |
| Drug | AC1NBU2S | 2.06e-04 | 117 | 164 | 6 | CID004473765 | |
| Drug | kazinol B | 2.32e-04 | 17 | 164 | 3 | CID000480869 | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 2.38e-04 | 170 | 164 | 7 | 4680_UP | |
| Drug | lavendustin A | 2.47e-04 | 171 | 164 | 7 | CID000003894 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.62e-07 | 3 | 162 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.62e-07 | 3 | 162 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | Mediastinal (Thymic) Large B-Cell Lymphoma | 3.00e-05 | 2 | 162 | 2 | C1292754 | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 8.95e-05 | 3 | 162 | 2 | C0349788 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | Liver carcinoma | KMT2B IRS1 UROC1 PPP1R1A KIF20A NCAPG BUB1 KIF14 KMT2A CDT1 EIF3H | 1.20e-04 | 507 | 162 | 11 | C2239176 |
| Disease | Myeloid Leukemia | 1.25e-04 | 18 | 162 | 3 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.25e-04 | 18 | 162 | 3 | C0023466 | |
| Disease | neuroticism measurement | CACNA1E FOXP2 ZMYND8 LMTK2 BRINP1 STX1B PTPN14 SEMA6D DPEP2 FARP1 KMT2A ALAS1 HERC1 CAMTA1 BAG6 | 1.55e-04 | 909 | 162 | 15 | EFO_0007660 |
| Disease | migraine (implicated_via_orthology) | 1.78e-04 | 4 | 162 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | specific developmental disorder (implicated_via_orthology) | 1.78e-04 | 4 | 162 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | hepatitis C virus infection, response to protease inhibitor, bilirubin measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0003047, EFO_0004570, EFO_0005657 | |
| Disease | age at diagnosis, substance-related disorder | 4.43e-04 | 6 | 162 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | eye disease (implicated_via_orthology) | 4.43e-04 | 6 | 162 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | EYA4 CFTR RBP3 MCC BRINP1 NCAPG MYLK3 AKAP9 BUB1 JAKMIP1 EIF3H DMD | 5.25e-04 | 702 | 162 | 12 | C0009402 |
| Disease | intellectual disability (is_implicated_in) | 5.91e-04 | 30 | 162 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 6.18e-04 | 7 | 162 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 6.18e-04 | 7 | 162 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | CASP8AP2 LPAR3 ADGRB3 MCC CATSPER3 ITPR2 HEATR6 RHOBTB1 KIF14 ARHGAP25 OLIG2 | 6.53e-04 | 619 | 162 | 11 | EFO_0003923, EFO_0004531 |
| Disease | Acute erythroleukemia - M6a subtype | 8.21e-04 | 8 | 162 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 8.21e-04 | 8 | 162 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 8.21e-04 | 8 | 162 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 8.21e-04 | 8 | 162 | 2 | C2930974 | |
| Disease | posterior thigh muscle fat infiltration measurement | 9.34e-04 | 35 | 162 | 3 | EFO_0020934 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.00e-03 | 80 | 162 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | hoarding disorder | 1.02e-03 | 36 | 162 | 3 | EFO_0803361 | |
| Disease | response to high fat food intake, triglyceride change measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0007681, EFO_0007684 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.31e-03 | 10 | 162 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Congenital small ears | 1.49e-03 | 41 | 162 | 3 | C0152423 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.55e-03 | 152 | 162 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | body weight | CACNA1B FOXP2 LCORL ESRRG TOM1L1 ADGRB3 IRS1 BRINP1 HUWE1 EYA2 BCL6 PTPN14 NR1I2 DNAH12 SEMA6D DMD | 1.62e-03 | 1261 | 162 | 16 | EFO_0004338 |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 1.68e-03 | 228 | 162 | 6 | EFO_0003948, MONDO_0004975 | |
| Disease | RS-6-hydroxywarfarin measurement | 1.69e-03 | 155 | 162 | 5 | EFO_0803328 | |
| Disease | reading | 1.71e-03 | 43 | 162 | 3 | EFO_0005229 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.91e-03 | 12 | 162 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | ascorbic acid 2-sulfate measurement | 2.25e-03 | 13 | 162 | 2 | EFO_0800169 | |
| Disease | depressive symptom measurement | 2.53e-03 | 426 | 162 | 8 | EFO_0007006 | |
| Disease | ventricular septal defect (is_implicated_in) | 2.61e-03 | 14 | 162 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | Left ventricular noncompaction | 2.61e-03 | 14 | 162 | 2 | C1960469 | |
| Disease | corneal topography | 3.11e-03 | 109 | 162 | 4 | EFO_0004345 | |
| Disease | Ciliopathies | 3.22e-03 | 110 | 162 | 4 | C4277690 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 3.42e-03 | 16 | 162 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | R-warfarin measurement | 3.53e-03 | 265 | 162 | 6 | EFO_0803324 | |
| Disease | Drug habituation | 3.77e-03 | 115 | 162 | 4 | C0013170 | |
| Disease | Drug abuse | 3.77e-03 | 115 | 162 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.77e-03 | 115 | 162 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.77e-03 | 115 | 162 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.77e-03 | 115 | 162 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.77e-03 | 115 | 162 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.77e-03 | 115 | 162 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.77e-03 | 115 | 162 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.77e-03 | 115 | 162 | 4 | C0029231 | |
| Disease | alpha-L-iduronidase measurement | 3.86e-03 | 17 | 162 | 2 | EFO_0020139 | |
| Disease | Substance abuse problem | 3.89e-03 | 116 | 162 | 4 | C0740858 | |
| Disease | sleep duration | 3.98e-03 | 362 | 162 | 7 | EFO_0005271 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 4.22e-03 | 59 | 162 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | adverse effect, response to xenobiotic stimulus | 4.22e-03 | 59 | 162 | 3 | EFO_0009658, GO_0009410 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 4.33e-03 | 18 | 162 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | body composition measurement | 4.34e-03 | 193 | 162 | 5 | EFO_0005106 | |
| Disease | atrial fibrillation | 4.54e-03 | 371 | 162 | 7 | EFO_0000275 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSPEMHIMEAQMEQL | 286 | Q8N6Y0 | |
| MGEIADAIKTLHMAM | 576 | Q7Z4L5 | |
| MRMVHIDEEMGPKTD | 531 | Q9H2P0 | |
| LAVHMHERGMDMDGE | 76 | A8MVZ5 | |
| ELIRQHMAQMEEMKT | 451 | Q99996 | |
| MERRMAEMTGSQQHK | 986 | Q9Y6Y1 | |
| QMDSTLQGDMRHMTL | 206 | P41214 | |
| DHRERAMMTMAVLSK | 666 | O71037 | |
| DHRERAMMTMAVLSK | 666 | Q902F8 | |
| MEMMRSLRHVNIDHL | 101 | O15372 | |
| VEDAEMMSRMASHGI | 236 | Q9Y646 | |
| MMSRMASHGIKIVIQ | 241 | Q9Y646 | |
| HHIGMQMRIAMFSLI | 146 | P13569 | |
| MDTPENVLQMLEAHM | 1 | O43683 | |
| NMFVGVMIMHTEDSI | 261 | Q86XQ3 | |
| VLMNMPVAEDMTVHF | 1791 | Q15878 | |
| NKNRMDFIHMVIGMS | 531 | O60477 | |
| MMHRLGEPQARMREE | 66 | Q9HBH7 | |
| VEPVVMMHMNIQDSG | 451 | P46379 | |
| TMMGLRLQVVLEHMP | 916 | P46379 | |
| VMVDMASNLMLVDEH | 486 | Q96PE1 | |
| GADMDIVHPQERMME | 1291 | O60242 | |
| VLMHMMLEAGAEANL | 266 | Q9Y574 | |
| EKTQRMSLMRHHMGQ | 766 | Q7Z2Y8 | |
| IMIAMLDRDHTGKMG | 96 | P28676 | |
| MFRSMDTIVGMLHNR | 196 | Q9H211 | |
| MRMCDRGIQMLITTV | 1 | O60359 | |
| MGCRHVQRTMLMDEQ | 451 | P52824 | |
| MMVDSAEDQKIHRPM | 221 | Q9H467 | |
| IMPHTEARIMNMEAG | 436 | Q96CM8 | |
| MEGDTQKLEVEHVMM | 1871 | A6QL64 | |
| AAEQRMVHRIQRIMM | 141 | Q5TEZ5 | |
| MVHRIQRIMMECHRE | 146 | Q5TEZ5 | |
| FAQIHTVREETMMVM | 1971 | P11532 | |
| GTLAMVSMHMRKLEV | 1531 | Q96M86 | |
| VSMHMRKLEVLVNFM | 1536 | Q96M86 | |
| VHNILAEMVMGGMVL | 116 | Q92572 | |
| VPSSEQEIMHMLRMI | 1031 | Q9UKL3 | |
| VRMNMPISNEDMTVH | 1776 | Q00975 | |
| RAPIKMSAHMAMVDA | 136 | Q5T5Y3 | |
| FDMRALDTPVMVHMD | 266 | Q9NV06 | |
| NQRLDMVPHLETDMM | 96 | Q9ULX6 | |
| HMLDLMSSIIMEGDG | 186 | Q29RF7 | |
| VDEMDMMHARAATLI | 96 | Q9H0B3 | |
| NVMRTIHGVGEMMTQ | 916 | Q14571 | |
| IHGVGEMMTQMVLSR | 921 | Q14571 | |
| GSIIMNRELESMAMR | 111 | Q9HCC9 | |
| STLGQMVNMHMEKVA | 91 | Q9P2A4 | |
| MVNMHMEKVARREIG | 96 | Q9P2A4 | |
| EVMKMIMTLNVQERG | 926 | O00763 | |
| MTKNMGVIAERMIEA | 886 | Q4KMQ2 | |
| LRNMAVGKHTLEFMM | 86 | P01906 | |
| LESMIRLSEAMARMH | 621 | Q14566 | |
| LRMKLHQQERDMAEM | 751 | Q15058 | |
| LEMEMEAARHEHQVM | 296 | Q15233 | |
| RHSMENMELMKLTPE | 406 | P81274 | |
| MAAAVRMNIQMLLEA | 1 | Q05195 | |
| VMEMMEGGELFHRIS | 101 | Q8IW41 | |
| HMPHMIDRIVMQELQ | 956 | Q3T906 | |
| RKLMHMADTIEEGTM | 101 | P11488 | |
| MRQMLMDAGLPVVHC | 511 | P13196 | |
| IVRAMTHVINQGMAM | 221 | Q14722 | |
| LDFLVDMHMQHMERL | 636 | O43525 | |
| DMHMQHMERLQVQVT | 641 | O43525 | |
| DHEIMEEAIAMVMSG | 526 | Q8N3X6 | |
| LMQMIEGMRHEEGEC | 761 | Q8IYD8 | |
| DVEMRAALQFLMRHM | 2556 | Q15751 | |
| SMHGDMPQKERESIM | 306 | P38919 | |
| EMRHIDMVEGDEGRM | 241 | P52789 | |
| SQMMMEDILRVGVTL | 946 | P29323 | |
| AMHGDMDQKERDVIM | 301 | P60842 | |
| EHSVGVQMRSAMPMV | 3711 | Q9NYQ8 | |
| VHMMFVGESAILLAM | 106 | Q96RD2 | |
| SIHIQEMDTPGEMLM | 336 | Q32MK0 | |
| ETLNRMHPMALHMVL | 266 | Q6ZU69 | |
| RLQAMMTHLHMRPSE | 401 | O15409 | |
| IVMQRMTIVNLEADM | 926 | O75037 | |
| MMGLMAVRHPDIEAQ | 656 | P48449 | |
| MHLELREGLTRMSMD | 571 | O94830 | |
| ARDVVMDMIKMGVSH | 1171 | Q6ZR08 | |
| QERDQMVRMALKHMG | 1126 | Q6AI08 | |
| HRNVMMRLNLQLTMG | 331 | Q9HD23 | |
| LVIAVERHMSIMRMR | 121 | Q9UBY5 | |
| ERHMSIMRMRVHSNL | 126 | Q9UBY5 | |
| EHMRGDSQTMLLQRM | 231 | Q8IWU2 | |
| ERLQAMMAHLHMRPS | 361 | Q8IVH2 | |
| SFMEDMVGILMRHSE | 1466 | Q9UMN6 | |
| MVELMGVQDQHMDER | 271 | Q96N16 | |
| QGLTEEQRMMIRELM | 141 | O75469 | |
| NMGMALLIRMDARLH | 46 | Q8NGR4 | |
| QMETIRHGVHMMVAT | 306 | Q9UJV9 | |
| IQAIMMMEESVQHVV | 136 | Q86VS8 | |
| AQNMHETILEAMRAM | 246 | P35568 | |
| MDMGFTREHAMEALL | 1326 | Q7Z6Z7 | |
| DHRERAMMTMAVLSK | 1426 | P63135 | |
| MHDLNLAMDGLREVM | 96 | Q7RTU3 | |
| IMDIVAQMREQRSGM | 381 | Q4JDL3 | |
| VMDLMGQLHRMNREE | 56 | P53611 | |
| ESQMMAMVERHETQV | 791 | P23508 | |
| MAVTLGLRMEEMIFN | 401 | O95677 | |
| DHRERAMMTMAVLSK | 666 | Q69384 | |
| TEMVAQLHGTMIKME | 721 | Q9Y4F1 | |
| QHMEDPRRAGKMLMT | 406 | P62508 | |
| KMDLLGMVVVDELHM | 206 | O75417 | |
| IQVMMMGSARVAELL | 51 | P42772 | |
| NLREGNIMAVMATAM | 96 | P41182 | |
| AMERMMHEEHLRQVE | 731 | Q8IY82 | |
| DELHVMMQRRMSQEN | 2616 | Q99698 | |
| VVAEMNRLGMMVDLS | 246 | Q9H4A9 | |
| PENIHMMIGSMTIDC | 2016 | Q03164 | |
| DHRERAMMTMVVLSK | 666 | Q902F9 | |
| QLMMTLTERMIAAEG | 341 | P57679 | |
| MKHNLELTMAEMRQS | 981 | Q9ULU4 | |
| SAAMMAIAIMKVHRI | 161 | Q969E2 | |
| TNAVMLQQHIRMHMG | 636 | Q9UJQ4 | |
| NLMRALGMHETVMEV | 2196 | P21817 | |
| LGMHETVMEVMVNVL | 2201 | P21817 | |
| NGMIARQMVDMLVES | 4036 | P21817 | |
| LMRALGMHETVMEVM | 2161 | Q92736 | |
| VTLSRDLHAMAEMMA | 2831 | Q92736 | |
| GVEMRLHNMSEAMAV | 331 | Q8TDX9 | |
| SNHQSILDMMGLMEV | 96 | O15120 | |
| QMRAMLDQLMGTSRD | 6 | Q9Y383 | |
| EQLFKMIRMSTGHME | 606 | Q8IWE5 | |
| MIRMSTGHMEGNLQL | 611 | Q8IWE5 | |
| SVRIGLMMEEMIFNL | 301 | O00167 | |
| LMMEEMIFNLADTHL | 306 | O00167 | |
| TAMQAMIRAMDTLRI | 81 | O95837 | |
| HFEMMRLTINRSMDP | 101 | Q9NX20 | |
| DMSVLEISGMIMNRV | 476 | Q8N3S3 | |
| LADIQSHMDRLMTQM | 296 | Q96DX7 | |
| HSELDMVKMNVRVMS | 206 | O75674 | |
| IRMTPSKIHMQEMEL | 456 | Q96D71 | |
| MQTLAHDVKMMTRDG | 171 | Q3ZLR7 | |
| EQQMVMRGHRDTSMV | 396 | Q9H9S3 | |
| LRQIFHVLDLMQMDM | 211 | Q8N4U5 | |
| NNRHMMIRGENMSKI | 231 | O43776 | |
| VHNKEVRMAEMVSMG | 1031 | Q58EX7 | |
| MVQETRRLHGMDMSV | 476 | P28749 | |
| GMNMEAIHVLLNFME | 336 | Q9NVN3 | |
| DGMRMHPEEMQRIHD | 1661 | Q9NTG1 | |
| HSLEVMNSMVRGMEA | 641 | Q15678 | |
| AREMAMMQEGEHTVT | 396 | Q9UL54 | |
| MHDLNIAMDGLREVM | 121 | Q13516 | |
| LETLMMELTGQMREA | 26 | Q7Z3Z2 | |
| MHREMQVNPISKRMG | 381 | O94844 | |
| RHMELEQMHVLDTPM | 86 | P17947 | |
| MLMLQGLIAARKHMD | 731 | Q9UBF8 | |
| EEALRVMDMLHSMGP | 166 | O00764 | |
| LHDMFMDIAMLVENQ | 211 | Q13277 | |
| VHMRAMSIAQRVMLL | 236 | Q9BPX3 | |
| IETKMHVRFLNMETM | 196 | Q96BS2 | |
| ILHVTFGMTDDMIMD | 56 | Q9HAE3 | |
| MGRMIITQQMEEIVR | 221 | Q9Y2G3 | |
| MAELGELKHMVMSFR | 1 | Q9Y6X2 | |
| RAAVMHDILDMMPEG | 686 | Q6P2Q9 | |
| HVGRMASVNMDPALM | 906 | Q9Y4G8 | |
| MDQIIEGNMKAHFIM | 391 | O75312 | |
| MPAIMTMLADHAARQ | 1 | O14980 | |
| IMHTDAMIIDMRFNI | 1071 | P10745 | |
| ARHEHQLMLMRQDLM | 311 | Q8WXF1 | |
| EQQMVMRGHRETSMV | 396 | P61619 | |
| ERTSLQVPMMHQKEM | 236 | Q86U17 | |
| MIFSHQIMSGGRDML | 796 | Q8N3U4 | |
| AAIMHMIMNNLDPAV | 101 | Q96N76 | |
| MHLRDEICNEMVEQM | 586 | O95235 | |
| HPNLMRVLGMHETVM | 2056 | Q15413 | |
| RVLGMHETVMEVMVN | 2061 | Q15413 | |
| TSIRELHDMFVDMAM | 206 | P61266 | |
| LHDMFVDMAMLVESQ | 211 | P61266 | |
| PQIQRVMTMMIRDHE | 336 | P42331 | |
| VMTMMIRDHEVLFPK | 341 | P42331 | |
| MREGLNVSKMMQAHI | 776 | P55017 | |
| MIREQRHSAMLLSMD | 306 | A6NIE6 | |
| ATMLVVLMEKMGDHL | 296 | Q9UK55 | |
| MSVNMDELRHQVMIN | 1 | Q8IYN6 | |
| GMVAMIMLRTLHKDI | 316 | Q99805 | |
| MNTDNLMRIFTMGID | 411 | Q9H9Y6 | |
| IMGDIQMAHQNLMLD | 896 | Q8NFY4 | |
| RREKIMAQMSEMQRH | 1041 | Q8IWV8 | |
| MTLERAVSMLEADHM | 351 | Q99959 | |
| RITPTMKELQMMVEH | 76 | Q13522 | |
| MKELQMMVEHHLGQQ | 81 | Q13522 | |
| SGDSVFHEEMMKMRQ | 11 | O75386 | |
| SMSGISMHRVKDAML | 371 | Q5TIE3 | |
| LMMMLQASLQEIGDR | 726 | O43264 | |
| IAMAVIQQKMDRHME | 406 | P57678 | |
| KMHIDRNTGIIEMFM | 1291 | P52179 |